BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11514580)

  • 1. Expression, purification, and characterization of recombinant HIV gp140. The gp41 ectodomain of HIV or simian immunodeficiency virus is sufficient to maintain the retroviral envelope glycoprotein as a trimer.
    Zhang CW; Chishti Y; Hussey RE; Reinherz EL
    J Biol Chem; 2001 Oct; 276(43):39577-85. PubMed ID: 11514580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoting trimerization of soluble human immunodeficiency virus type 1 (HIV-1) Env through the use of HIV-1/simian immunodeficiency virus chimeras.
    Center RJ; Lebowitz J; Leapman RD; Moss B
    J Virol; 2004 Mar; 78(5):2265-76. PubMed ID: 14963123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression, purification, and characterization of gp160e, the soluble, trimeric ectodomain of the simian immunodeficiency virus envelope glycoprotein, gp160.
    Chen B; Zhou G; Kim M; Chishti Y; Hussey RE; Ely B; Skehel JJ; Reinherz EL; Harrison SC; Wiley DC
    J Biol Chem; 2000 Nov; 275(45):34946-53. PubMed ID: 10944528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein.
    Schülke N; Vesanen MS; Sanders RW; Zhu P; Lu M; Anselma DJ; Villa AR; Parren PW; Binley JM; Roux KH; Maddon PJ; Moore JP; Olson WC
    J Virol; 2002 Aug; 76(15):7760-76. PubMed ID: 12097589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stoichiometry of trimeric SIV glycoprotein interaction with CD4 differs from that of anti-envelope antibody Fab fragments.
    Kim M; Chen B; Hussey RE; Chishti Y; Montefiori D; Hoxie JA; Byron O; Campbell G; Harrison SC; Reinherz EL
    J Biol Chem; 2001 Nov; 276(46):42667-76. PubMed ID: 11544255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational States of a Soluble, Uncleaved HIV-1 Envelope Trimer.
    Liu Y; Pan J; Cai Y; Grigorieff N; Harrison SC; Chen B
    J Virol; 2017 May; 91(10):. PubMed ID: 28250125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the V2 loop derived from SF162, an R5-tropic human immunodeficiency virus type 1 isolate.
    Srivastava IK; Stamatatos L; Kan E; Vajdy M; Lian Y; Hilt S; Martin L; Vita C; Zhu P; Roux KH; Vojtech L; C Montefiori D; Donnelly J; Ulmer JB; Barnett SW
    J Virol; 2003 Oct; 77(20):11244-59. PubMed ID: 14512572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific amino acids in the N-terminus of the gp41 ectodomain contribute to the stabilization of a soluble, cleaved gp140 envelope glycoprotein from human immunodeficiency virus type 1.
    Dey AK; David KB; Klasse PJ; Moore JP
    Virology; 2007 Mar; 360(1):199-208. PubMed ID: 17092531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional structures of soluble CD4-bound states of trimeric simian immunodeficiency virus envelope glycoproteins determined by using cryo-electron tomography.
    White TA; Bartesaghi A; Borgnia MJ; de la Cruz MJ; Nandwani R; Hoxie JA; Bess JW; Lifson JD; Milne JL; Subramaniam S
    J Virol; 2011 Dec; 85(23):12114-23. PubMed ID: 21937655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Approach to Produce HIV-1 Envelope Trimers: BOTH CLEAVAGE AND PROPER GLYCOSYLATION ARE ESSENTIAL TO GENERATE AUTHENTIC TRIMERS.
    AlSalmi W; Mahalingam M; Ananthaswamy N; Hamlin C; Flores D; Gao G; Rao VB
    J Biol Chem; 2015 Aug; 290(32):19780-95. PubMed ID: 26088135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, expression, and immunogenicity of a soluble HIV trimeric envelope fragment adopting a prefusion gp41 configuration.
    Qiao ZS; Kim M; Reinhold B; Montefiori D; Wang JH; Reinherz EL
    J Biol Chem; 2005 Jun; 280(24):23138-46. PubMed ID: 15833740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a stable HIV-1 B/C recombinant, soluble, and trimeric envelope glycoprotein (Env) highly resistant to CD4-induced conformational changes.
    Kumar R; Ozorowski G; Kumar V; Holden LG; Shrivastava T; Patil S; Deshpande S; Ward AB; Bhattacharya J
    J Biol Chem; 2017 Sep; 292(38):15849-15858. PubMed ID: 28743743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus.
    Chertova E; Bess JW; Crise BJ; Sowder II RC; Schaden TM; Hilburn JM; Hoxie JA; Benveniste RE; Lifson JD; Henderson LE; Arthur LO
    J Virol; 2002 Jun; 76(11):5315-25. PubMed ID: 11991960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities.
    Earl PL; Broder CC; Long D; Lee SA; Peterson J; Chakrabarti S; Doms RW; Moss B
    J Virol; 1994 May; 68(5):3015-26. PubMed ID: 7512157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding.
    Sattentau QJ; Moore JP; Vignaux F; Traincard F; Poignard P
    J Virol; 1993 Dec; 67(12):7383-93. PubMed ID: 7693970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Processing, stability, and receptor binding properties of oligomeric envelope glycoprotein from a primary HIV-1 isolate.
    Staropoli I; Chanel C; Girard M; Altmeyer R
    J Biol Chem; 2000 Nov; 275(45):35137-45. PubMed ID: 10926931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.
    Sanders RW; Vesanen M; Schuelke N; Master A; Schiffner L; Kalyanaraman R; Paluch M; Berkhout B; Maddon PJ; Olson WC; Lu M; Moore JP
    J Virol; 2002 Sep; 76(17):8875-89. PubMed ID: 12163607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein.
    Richardson TM; Stryjewski BL; Broder CC; Hoxie JA; Mascola JR; Earl PL; Doms RW
    J Virol; 1996 Feb; 70(2):753-62. PubMed ID: 8551612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures.
    Harris A; Borgnia MJ; Shi D; Bartesaghi A; He H; Pejchal R; Kang YK; Depetris R; Marozsan AJ; Sanders RW; Klasse PJ; Milne JL; Wilson IA; Olson WC; Moore JP; Subramaniam S
    Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11440-5. PubMed ID: 21709254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and characterization of oligomeric envelope glycoprotein from a primary R5 subtype B human immunodeficiency virus.
    Srivastava IK; Stamatatos L; Legg H; Kan E; Fong A; Coates SR; Leung L; Wininger M; Donnelly JJ; Ulmer JB; Barnett SW
    J Virol; 2002 Mar; 76(6):2835-47. PubMed ID: 11861851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.